ad image

Cardinal Health

1 / 1
Building a Regulatory Roadmap for IND, NDA, and BLA
IND, NDA, and BLA

Building a Regulatory Roadmap for IND, NDA, and BLA

Rebecca Lamb-Wharton, Ph.D.; Brenda Schlenk, RPh; Mamadou Diallo, PharmD

PAO-03-24-CL-10Mar 26, 2024
Cardinal Health
FDA

FDA Advisory Committee Votes in Favor of Cardinal Health's INCRAFT® AAA Stent Graft System for the Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysms

Cardinal Health

PR-M06-18-NI-055Jun 15, 2018
1 / 1